Automated synthesis of Ga-68/Lu-177-PSMA on the Trasis miniAllinOne

Keyphrases

• Prostate-specific Antigen 100%
• Lutetium-177 (177Lu) 100%
• Automated Synthesis 100%
• Ga-68 100%
• Good Manufacturing Practice 57%
• Prostate Cancer 28%
• HBED-CC 28%
• Positron Emission Tomography 14%
• Clinical Data 14%
• Clinical Application 14%
• Radioligand 14%
• Positron Emission Tomography-computed Tomography (PET-CT) 14%
• Radiotracer 14%
• Theranostics 14%
• Metastatic Castration-resistant Prostate Cancer (mCRPC) 14%
• Radiochemistry 14%
• Synthetic Data 14%
• Production Methods 14%
• Radiotherapeutics 14%
• Synthesis Modules 14%
• Recurrent Prostate Cancer 14%
• Radioligand Therapy 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Specific Membrane Antigen 100%
• Lutetium 177 100%
• Good Manufacturing Practice 57%
• Prostate Cancer 42%
• Radioligand 28%
• Gallium 68 28%
• Tracer 14%
• Computed Tomography Studies 14%
• Castration Resistant Prostate Cancer 14%

Immunology and Microbiology

• Prostate Specific Membrane Antigen 100%
• Prostate 57%
• Positron Emission Tomography 14%
• Positron Emission Tomography-Computed Tomography 14%